Biotechnology
- 516.407
- +3.040+0.59%
Trading Aug 12 09:37 CST
517.851High512.335Low
0.000Open513.367Pre Close5.30MVolume10Rise108.25P/E (Static)90.98MTurnover2Flatline0.04%Turnover Ratio516.32BMarket Cap2Fall351.79BFloat Cap
Sign in to post a comment
$WUXI BIO (02269.HK)$ pls revert to uptrend
1
In Q2, $WUXI APPTEC (02359.HK)$ ’s revenue was 9.261 billion yuan, up 16% quarter-over-quarter but down 6.5% year-over-year.
Adjusted non-IFRS net profit for Q2 was 2.46 billion yuan, up 28.5% quarter-over-quarter but down 10.6% year-over-year.
Revenue from U.S. clients was 10.71 billion yuan, down 1.2% year-over-year excluding specific commercial...
Adjusted non-IFRS net profit for Q2 was 2.46 billion yuan, up 28.5% quarter-over-quarter but down 10.6% year-over-year.
Revenue from U.S. clients was 10.71 billion yuan, down 1.2% year-over-year excluding specific commercial...
2
$WUXI APPTEC (02359.HK)$ ’s interim net profit slipped 20%, and the stock opened 3% higher at $29.6. $WUXI BIO (02269.HK)$ , under the same series, lifted 1.3%. Zhong Shanshan's YANGSHENGTANG increased stake in $NONGFU SPRING (09633.HK)$ by a total of 1.83 million shares, and the stock opened flat at $30.4 this morning.
1
2
$WUXI BIO (02269.HK)$ Hopefully after Trump takes over . He'll unlock 🔑 this monster 👹
$HSI Futures Current Contract (HSIcurrent.HK)$
$HSI Futures Current Contract (HSIcurrent.HK)$
2
3
No comment yet
103115047 : In the Middle East war, the demand for medicines will increase dramatically.